Alibaba Health Information Technology Limited
ALBBY · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $2,320,761 | $16,324,568 | $8,162,284 | $14,273,724 |
| % Growth | -85.8% | 100% | -42.8% | – |
| Cost of Goods Sold | $1,740,390 | $12,426,242 | $6,213,121 | $10,739,959 |
| Gross Profit | $580,371 | $3,898,326 | $1,949,163 | $3,533,765 |
| % Margin | 25% | 23.9% | 23.9% | 24.8% |
| R&D Expenses | $43,518 | $400,832 | $200,416 | $319,221 |
| G&A Expenses | $0 | $224,565 | $112,283 | $182,867 |
| SG&A Expenses | $381,305 | $2,804,344 | $1,402,172 | $2,429,169 |
| Sales & Mktg Exp. | $0 | $1,277,676 | $638,838 | $980,698 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $424,823 | $3,205,176 | $1,602,588 | $2,748,390 |
| Operating Income | $155,548 | $693,150 | $346,575 | $785,375 |
| % Margin | 6.7% | 4.2% | 4.2% | 5.5% |
| Other Income/Exp. Net | $43,106 | $45,749 | $22,875 | $35,694 |
| Pre-Tax Income | $198,654 | $738,899 | $369,450 | $821,069 |
| Tax Expense | $22,633 | $75,933 | $37,967 | $52,021 |
| Net Income | $176,051 | $663,474 | $331,737 | $768,953 |
| % Margin | 7.6% | 4.1% | 4.1% | 5.4% |
| EPS | 0.22 | 0.82 | 0.41 | 0.96 |
| % Growth | -73.2% | 100% | -57.3% | – |
| EPS Diluted | 0.22 | 0.82 | 0.41 | 0.96 |
| Weighted Avg Shares Out | 806,062 | 808,799 | 808,799 | 804,344 |
| Weighted Avg Shares Out Dil | 810,097 | 808,754 | 808,754 | 804,826 |
| Supplemental Information | – | – | – | – |
| Interest Income | $32,236 | $254,706 | $127,353 | $231,259 |
| Interest Expense | $95 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,276 | $18,873 | $9,437 | $13,261 |
| EBITDA | $204,321 | $700,047 | $350,024 | $785,699 |
| % Margin | 8.8% | 4.3% | 4.3% | 5.5% |